Furthermore, by constructing MC38 tumor model using Rag1−/− mice (which lack T cells and B cells), we showed that anti-PVRIG mAb was effective even in the absence of adaptive immunity, suggesting the importance of NK cells in PVRIG-targeted treatments. This evidence concerns the gene RAG1 and neoplasm.